A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

NCT06165250 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Primary Hypercholesterolemia

Interventions

DRUG: BR1018A
DRUG: BR1018A-1
DRUG: BR1018B
DRUG: BR1018B-1
DRUG: BR1018C
DRUG: BR1018C-1

Sponsor

Boryung Pharmaceutical Co., Ltd